The following peer-reviewed papers directly related to Cimbi have been published in 2009.

1. Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, Baaré WF, Rasmussen PM, Madsen J, Paulson OB, Knudsen GM. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage. 2009 May 15;46(1):23-30.
2. Frokjaer VG, Erritzoe D, Madsen J, Paulson OB, Knudsen GM. Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding. Neuroscience 2009 Oct 6;163(2):640-5.
3. Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baare W, Budtz-Joergensen E, Madsen K, Madsen J, Kessing LV, Knudsen GM. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage 2009 Jun;46(2):360-6.
4. Gillings N. A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma. Nucl Med Biol 2009 Nov;36(8):961-5.
5. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 2009 Apr;15(2):187-95.
6. Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rosch F. Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET. Bioorg Med Chem 2009 Apr 15;17(8):2989-3002.
7. Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, Hashemi SH, Baare WF, Madsen J, Hasselbalch SG, Kringelbach ML, Mortensen EL, Knudsen GM. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage 2009 Apr 1;45(2):280-5.
8. Kalbitzer J, Svarer C, Frokjaer VG, Erritzoe D, Baare WF, Madsen J, Hasselbalch SG, Knudsen GM. A Probabilistic Approach to Delineating Functional Brain Regions. J Nucl Med Technol 2009 Jun;37(2):91-5.
9. Knorr U, Vinberg M, Klose M, Feldt-Rasmussen U, Hilsted L, Gade A, Haastrup E, Paulson O, Wetterslev J, Gluud C, Gether U, Kessing L. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. Trials 2009;10:66.
10. Knudsen GM. Testing for radioligand sensitivity to endogenous neurotransmitter release. Eur J Nucl Med Mol Imaging 2009 Jan 27;36:472-4.
11. Kornum BR, Lind NM, Gillings N, Marner L, Andersen F, Knudsen GM. Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Gottingen minipig. J Cereb Blood Flow Metab 2009 Jan;29(1):186-96.
12. Kupers R, Frokjaer VG, Naert A, Christensen R, Budtz-Joergensen E, Kehlet H, Knudsen GM. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation. Neuroimage 2009 Feb 1;44(3):1001-7.
13. Kupers R, Schneider FC, Christensen R, Naert A, Husted H, Paulson OB, Kehlet H. No evidence for generalized increased postoperative responsiveness to pain: a combined behavioral and serial functional magnetic resonance imaging study. Anesth Analg 2009 Aug;109(2):600-6.
14. Lehel S, Madsen J, Gillings N. HPLC methods for the purification of [11C}-labelled radiopharmaceuticals: reversal of the retention of products and precursors. J Label Compd Radiopharm 2009;52:177-81.
15. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 2009 Jun;109(5):1363-74.
16. Marner L, Gillings N, Comley RA, Baare WF, Rabiner EA, Wilson AA, Houle S, Hasselbalch SG, Svarer C, Gunn RN, Laruelle M, Knudsen GM. Kinetic Modeling of 11C-SB207145 Binding to 5-HT4 Receptors in the Human Brain In Vivo. J Nucl Med 2009 Jun;50(6):900-8.
17. Marner L, Knudsen GM, Haugbol S, Holm S, Baare W, Hasselbalch SG. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Eur J Nucl Med Mol Imaging 2009 Feb;36(2):287-93.
18. Nielsen FA. Lost in localization: a solution with neuroinformatics 2.0? Neuroimage 2009 Oct 15;48(1):11-3.
19. Nielsen FA. Visualizing data mining results with the brede tools. Front Neuroinformatics 2009;3:26.1-12.
20. Nielsen TR, Kornum BR, Moustgaard A, Gade A, Lind NM, Knudsen GM. A novel spatial Delayed Non-Match to Sample (DNMS) task in the Gottingen minipig. Behav Brain Res 2009 Jan 3;196(1):93-8.
21. Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson K, Lyons MJ, Grant MD, Franz CE, Xian H, Tsuang M, Fischl B, Seidman L, Dale A, Kremen WS. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex 2009 Nov;19(11):2728-35.
22. Ramsoy TZ, Liptrot MG, Skimminge A, Lund TE, Sidaros K, Christensen MS, Baare W, Paulson OB, Jernigan TL. Regional activation of the human medial temporal lobe during intentional encoding of objects and positions. Neuroimage 2009 Oct 1;47(4):1863-72.
23. Syvanen S, Lindhe O, Palner M, Kornum BR, Rahman O, Langstrom B, Knudsen GM, Hammarlund-Udenaes M. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on p-glycoprotein transport. Drug Metab Dispos 2009 Mar;37(3):635-43.
24. Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 2009 May;56(6-7):1001-9.
25. Trajkovska V, Kirkegaard L, Krey G, Marcussen AB, Thomsen MS, Chourbaji S, Brandwein C, Ridder S, Halldin C, Gass P, Knudsen GM, Aznar S. Activation of glucocorticoid receptors increases 5-HT2A receptor levels. Exp Neurol 2009 Jul;218(1):83-91.
26. Trajkovska V, Santini MA, Marcussen AB, Thomsen MS, Hansen HH, Mikkelsen JD, Arneberg L, Kokaia M, Knudsen GM, Aznar S. BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures. Neurochem Int 2009 Dec;55(7):697-702.
27. Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology 2009 Oct;34(9):1380-9.
28. Wilkowski B, Szewczyk MM, Rasmussen PM, Hansen LK, Nielsen FA. Coordinate-based meta-analytic search for the SPM neuroimaging pipeline - The BredeQuery plugin for SPM5. Healthinf 2009;11-7.